Literature DB >> 7539144

Macrophage-colony-stimulating factor regulates expression of the integrins alpha 4 beta 1 and alpha 5 beta 1 by murine bone marrow macrophages.

M Shima1, S L Teitelbaum, V M Holers, C Ruzicka, P Osmack, F P Ross.   

Abstract

We observed that when monocyte/macrophage precursors derived from murine bone marrow were treated with macrophage-colony-stimulating factor (M-CSF), there was a dose-dependent increase in both the number of adherent cells and the degree to which the cells were highly spread. Attachment was supported by fibronectin, but not by vitronectin or laminin, suggesting that the integrins alpha 4 beta 1 and/or alpha 5 beta 1 might mediate this event. Binding to fibronectin was blocked partially by antibodies to either integrin, and inhibition was almost complete when the antibodies were used in combination. By a combination of surface labeling with 125I and metabolic labeling with [35S]methionine and [35S]cysteine, we demonstrated that M-CSF treatment led to increased synthesis and surface expression of the two beta 1 integrins. Since attachment to fibronectin and/or stromal cells plays an important role in the maturation of other hematopoietic lineages, we propose that the action of M-CSF in the differentiation of immature monocytes/macrophages includes stimulated expression of the integrins alpha 4 beta 1 and alpha 5 beta 1, leading to interactions with components of the marrow microenvironment necessary for cell maturation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539144      PMCID: PMC41872          DOI: 10.1073/pnas.92.11.5179

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Cell attachment controls fibronectin and alpha 5 beta 1 integrin levels in fibroblasts. Implications for anchorage-dependent and -independent growth.

Authors:  S L Dalton; E E Marcantonio; R K Assoian
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

Review 2.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts.

Authors:  A Miyauchi; J Alvarez; E M Greenfield; A Teti; M Grano; S Colucci; A Zambonin-Zallone; F P Ross; S L Teitelbaum; D Cheresh
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

4.  Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells.

Authors:  D H Ryan; B L Nuccie; C N Abboud; J M Winslow
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

5.  Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages.

Authors:  M O De Nichilo; G F Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Immunobiochemical evidence for the loss of sperm specific histones during male pronucleus formation in monospermic zygotes of sea urchins.

Authors:  M Imschenetzky; M Puchi; C Pimentel; A Bustos; M Gonzales
Journal:  J Cell Biochem       Date:  1991-09       Impact factor: 4.429

7.  Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells.

Authors:  P J Simmons; B Masinovsky; B M Longenecker; R Berenson; B Torok-Storb; W M Gallatin
Journal:  Blood       Date:  1992-07-15       Impact factor: 22.113

8.  Human hematopoietic stem cell adherence to cytokines and matrix molecules.

Authors:  M W Long; R Briddell; A W Walter; E Bruno; R Hoffman
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

9.  Mechanisms of differentiation of U937 leukemic cells induced by GM-CSF and 1,25(OH)2 vitamin D3.

Authors:  Y R Kim; N G Abraham; J D Lutton
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

10.  Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.

Authors:  C M Verfaillie; J B McCarthy; P B McGlave
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  7 in total

1.  A stromal cell line from rainbow trout spleen, RTS34ST, that supports the growth of rainbow trout macrophages and produces conditioned medium with mitogenic effects on leukocytes.

Authors:  R C Ganassin; N C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-02       Impact factor: 2.416

2.  Macrophage motility requires distinct α5β1/FAK and α4β1/paxillin signaling events.

Authors:  Michelle Y Abshire; Keena S Thomas; Katherine A Owen; Amy H Bouton
Journal:  J Leukoc Biol       Date:  2010-11-17       Impact factor: 4.962

Review 3.  Extracellular matrix and lung inflammation.

Authors:  J Roman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  A tale of two niches: differential functions for VCAM-1 in satellite cells under basal and injured conditions.

Authors:  Hyo-Jung Choo; James P Canner; Katherine E Vest; Zachary Thompson; Grace K Pavlath
Journal:  Am J Physiol Cell Physiol       Date:  2017-07-12       Impact factor: 4.249

5.  CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes.

Authors:  Antonia Wimmer; Sophia K Khaldoyanidi; Martin Judex; Naira Serobyan; Richard G Discipio; Ingrid U Schraufstatter
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

Review 6.  Hemato-vascular origins of endothelial progenitor cells?

Authors:  Hsu Chao; Karen K Hirschi
Journal:  Microvasc Res       Date:  2010-02-10       Impact factor: 3.514

7.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.